Activate Anywhere Cohort 2024 FellowFounded in 2015, Activate empowers scientists and engineers to reinvent the world by launching startups to address climate change and other global challenges. Working between government, philanthropy, universities, and the private sector, Activate transforms scientists and engineers into high-impact entrepreneurs through the Activate Fellowship, a two-year immersive experience that equips science entrepreneurs with the skills, networks, infrastructure, and funding they need to quickly and effectively bring their groundbreaking research to market. Activate is a 501(c)(3) nonprofit and does not charge any fee nor equity for fellows to participate. Activate’s entrepreneurial fellowship model originated at Cyclotron Road, founding Activate partner and the first U.S. Department of Energy's Lab Embedded Entrepreneurship Program (LEEP) started at Lawrence Berkeley National Laboratory. Activate supports fellows in communities across the U.S.: Activate Berkeley, Activate Boston, Activate New York, Activate Houston, and Activate Anywhere. Learn more at Activate.org.

N1 Life is developing novel drug delivery technologies to overcome barriers in drug accessibility, both in the pharmacological sense and at the society level. Serving in a part-time advisory role, responsible for various aspects of project oversight, delivery tech design and development, experimental design and data analysis, payload selection and development, advising pipeline and IP strategy, assisting grant-writing or other fundraising needs, and generally helping N1 Life achieve its goals in bringing transformative delivery technologies to life.

ExciPlex is developing novel mycotoxin detection strategies to improve toxin traceability across the animal feed production chain and ultimately contribute to greater efficiency and productivity in livestock industries.Founded company, invented novel photochemical detection technique and smartphone-associated portable spectrometer. Responsible for all functions related to bringing this disruptive innovation to feed and livestock industries all over the world, seeking to help ensure the health and nutrition of these animals (aquatic and terrestrial), to protect farmer profitability, and to promote more efficient and sustainable protein production.Secured the following awards, grants, and investments:2020 Hatch Accelerator Program and Pre-Seed Investment (Cohort 4.0)NSF SBIR Phase I Awardee (diagnostic science tech)2021 Bayer Crop Science Startup Competition Finalist2021 Hello Tomorrow Deep Tech Pioneer2022 Farm Bureau Ag Innovation Challenge Semi-Finalist

Development of visible light-mediated intramolecular [3+2] cycloadditions converting aminocyclopropanes to 1-aminonorbornanes, employing photoredox catalysis for N,N-dialkylamino systems and a novel Schiff base photoauxiliary strategy for primary amine scaffolds; application of 1-aminonorbornanes as metabolically-inert bioisosteres for anilines, enabling the production of re-engineered drugs, drug leads, and agrochemicals: specific applications - KCNQ agonists (epilepsy, hearing loss), SDH inhibitors (broad-spectrum fungicide), EGFR/HER2 inhibitors (cancer).

Applied aniline bioisosterism concept to re-engineer drugs and drugs leads susceptible to metabolism-driven toxicity.